Verano Holdings (VRNO) Cost of Revenue (2021 - 2026)
Verano Holdings (VRNO) reported Cost of Revenue of $109.2 million for Q1 2026, down 0.93% year-over-year from $110.2 million in Q1 2025, and up 8.21% quarter-over-quarter from $100.9 million in Q4 2025.
Verano Holdings (VRNO) Cost of Revenue (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Cost of Revenue data on file, last reported at $109.2 million in Q1 2026.
- Cost of Revenue for Q1 2026 came in at $109.2 million, down 0.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $407.0 million (down 6.77% YoY), and the FY2025 annual result was $408.0 million, down 6.13% from the prior year.
- Cost of Revenue advanced to $109.2 million in Q1 2026 per VRNO's latest filing, from $100.9 million in the prior quarter.
- Over five years, Cost of Revenue peaked at $125.5 million in Q2 2022 and troughed at $1.1 million in Q1 2022.
- A 5-year average of $104.1 million and a median of $108.3 million in 2024 frame the typical range for Cost of Revenue.
- The sharpest annual moves came in 2023 and 2025: Cost of Revenue jumped 11104.85% in 2023, then declined 17.36% in 2025.
- A 5-year view of Cost of Revenue shows it stood at $122.6 million in 2022, then dropped by 2.46% to $119.6 million in 2023, then declined by 7.45% to $110.7 million in 2024, then declined by 8.81% to $100.9 million in 2025, then gained by 8.21% to $109.2 million in 2026.
- Business Quant data shows VRNO's Cost of Revenue at $109.2 million in Q1 2026, $100.9 million in Q4 2025, and $107.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 696.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 641.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 133.40 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 34.44 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 13.80 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 586.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 155.56 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 52.68 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 222.00 Mn |
| 10 | Verano Holdings | - | - | 98.98 Mn | 109.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 109.20 Mn |
| Mar 31, 2026 | 109.20 Mn |
| Dec 31, 2025 | 100.92 Mn |
| Dec 31, 2025 | 100.92 Mn |
| Sep 30, 2025 | 107.57 Mn |
| Sep 30, 2025 | 107.57 Mn |
| Jun 30, 2025 | 89.29 Mn |
| Jun 30, 2025 | 89.29 Mn |
| Mar 31, 2025 | 110.23 Mn |
| Mar 31, 2025 | 110.23 Mn |
| Dec 31, 2024 | 110.67 Mn |
| Dec 31, 2024 | 110.67 Mn |
| Sep 30, 2024 | 107.59 Mn |
| Sep 30, 2024 | 107.59 Mn |
| Jun 30, 2024 | 108.05 Mn |
| Jun 30, 2024 | 108.05 Mn |
| Mar 31, 2024 | 108.35 Mn |
| Mar 31, 2024 | 108.35 Mn |
| Dec 31, 2023 | 119.58 Mn |
| Dec 31, 2023 | 119.58 Mn |